Ilaria Grazia Zizzari Selected Research

Ilaria Grazia Zizzari Research Topics

Disease

20	Neoplasms (Cancer) 06/2022 - 01/2011
4	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2018
4	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 10/2020
2	Ascites 01/2017 - 01/2011
1	Glioblastoma (Glioblastoma Multiforme) 06/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	medullary Thyroid cancer 01/2021
1	Carcinogenesis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Ovarian Epithelial Carcinoma 10/2020
1	Inflammation (Inflammations) 09/2020
1	Uveal melanoma 07/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Vulvar Neoplasms (Vulvar Cancer) 10/2016
1	Hypersensitivity (Allergy) 01/2015
1	Infections 01/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2016
4	Proteins (Proteins, Gene)FDA Link 07/2021 - 12/2011
4	NivolumabIBA 01/2021 - 01/2019
4	AntigensIBA 01/2017 - 01/2011
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	Monoclonal AntibodiesIBA 01/2021 - 01/2011
2	LectinsIBA 06/2022 - 10/2020
2	Polysaccharides (Glycans)IBA 06/2022 - 10/2020
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 01/2017
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2020 - 01/2015
2	C-Type Lectins (C-Type Lectin)IBA 10/2020 - 01/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2020 - 01/2018
2	CytokinesIBA 09/2020 - 12/2016
2	AntibodiesIBA 01/2020 - 01/2011
2	Peptides (Polypeptides)IBA 04/2016 - 12/2011
1	LigandsIBA 06/2022
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2021
1	PlatinumIBA 01/2021
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	cabozantinibIBA 01/2021
1	pembrolizumabIBA 01/2021
1	AutoantibodiesIBA 12/2020
1	Immunoglobulin M (IgM)IBA 12/2020
1	SugarsIBA 10/2020
1	Vicia lectinsIBA 10/2020
1	ChemokinesIBA 09/2020
1	Bevacizumab (Avastin)FDA Link 03/2019
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Cancer VaccinesIBA 01/2018
1	AldehydesIBA 01/2018
1	VaccinesIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 12/2016
1	Interleukin-2 (IL2)IBA 12/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2016
1	AC133 AntigenIBA 10/2016
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	ParaffinIBA 10/2016
1	Monatide (IMS 3015)IBA 04/2016
1	Carcinoembryonic AntigenIBA 04/2016
1	CarbohydratesIBA 01/2015
1	AutoantigensIBA 01/2015
1	EpitopesIBA 12/2011
1	Immunoglobulin G (IgG)IBA 12/2011
1	Complementary DNA (cDNA)IBA 12/2011
1	oregovomabIBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2011
1	Epithelial Cell Adhesion MoleculeIBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Trastuzumab (Herceptin)FDA Link 01/2011
1	farletuzumabIBA 01/2011
1	human ERBB2 proteinIBA 01/2011

Therapy/Procedure

11	Immunotherapy 05/2022 - 12/2011
10	Therapeutics 05/2022 - 01/2011
1	Immunomodulation 05/2022
1	Drug Therapy (Chemotherapy) 03/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018